HMG-CoA Reductase Inhibitors, Other Lipid-Lowering Medication, Antiplatelet Therapy, and the Risk of Venous Thrombosis

Journal of Thrombosis and Haemostasis - United Kingdom
doi 10.1111/j.1538-7836.2008.03235.x
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Pleiotropic Effects of the HMG-CoA Reductase Inhibitors

International Journal of General Medicine
Medicine
2011English

HMG-CoA Reductase Inhibitors and the Risk of Hip Fractures in Elderly Patients

JAMA - Journal of the American Medical Association
Medicine
2000English

HMG CoA Reductase Inhibitors (Statins) for Dialysis Patients

2009English

Inflammation, Immunity, and HMG-CoA Reductase Inhibitors: Statins as Antiinflammatory Agents?

Circulation
Cardiovascular MedicinePhysiologyCardiology
2004English

Cholesterol, C-Reactive Protein, and Periodontitis: HMG-CoA-Reductase Inhibitors (Statins) as Effect Modifiers

ISRN Dentistry
2011English

Role of HMG-CoA Reductase Inhibitors With Curative Radiotherapy in Men With Prostate Cancer

Research and Reports in Urology
Urology
2011English

Effects of Combined Therapy Using HMG-CoA Reductase Inhibitor and Colestimide on Refractory Hypercholesterolemia

The Journal of Japan Atherosclerosis Society
2002English

HMG CoA Reductase Inhibitors (Statins) for People With Chronic Kidney Disease Not Requiring Dialysis

Cochrane Database of Systematic Reviews
2014English

Features of the HMG 1 Subfamily of Genes Encoding HMG-CoA Reductase in Potato

Plant Molecular Biology
MedicineGeneticsAgronomyPlant ScienceCrop Science
1995English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy